Natural History Study for Patients With Angelman Syndrome

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-10-10

Study Completion Date

2028-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a 9-year natural history study for patients with Angelman syndrome in Belgium (a genetic neurodevelopmental disorder, affecting 500,000 individuals in the world). It includes a 3-year recruitment phase, a 5 year follow-up and a year to analyze the collected data. The investigators plan to include 30 patients with a semi-annual follow-up for 4 years.

The investigators will collect relevant retrospective and prospective data using age-standardized scales and questionnaires for functional motor assessments and global developmental assessment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Use of Eye Tracking to Study Social Perception Abnormalities in Children With Angelman Syndrome

NCT06737718

Angelman Syndrome

RECRUITING

Study on the Brain Network of Angelman Syndrome

NCT03358823

Angelman Syndrome

COMPLETED

Clinical Characterization of Frequent Monogenic Forms of Neurodevelopmental Disorders

NCT04979182

Neurodevelopmental Disorders

UNKNOWN

Neuropsychological and Psychosocial Follow up of Children and Adolescents With Neuromuscular Disease

NCT02253290

Neuromuscular Diseases

RECRUITING

Study of the Prevalence of Autistic Traits in Angelman Syndrome

NCT06337383

Angelman Syndrome

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients are seen every six months for five years. In these visits, patient have medical review (general medical examination, neurological examination), vital signs (height, weight, respiratory rate, heart rate, blood pressure), cognitive assessment (Bayley-IV), language assessment and questionaire (Bayley-IV, ORCA), motor assessments (Bayley-IV, FMS, Developmental milestones and HINE), quality of life questionnaire (PedsQL, CGI-CASS) and general development questionnaire (Vineland-II).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Angelman Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Genetically confirmed diagnosis of AS
* 0-99 years
* Male or Female
* Participant's carer is willing to give IC/sign a "record of consultation" for participation in the study